Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Receivables - Other: 2018-2021

Historic Receivables - Other for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Dec 2021 value amounting to $1.1 million.

  • Avadel Pharmaceuticals' Receivables - Other fell 23.25% to $1.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year decrease of 23.25%. This contributed to the annual value of $1.1 million for FY2021, which is 23.25% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Receivables - Other of $1.1 million as of FY2021, which was down 23.25% from $1.4 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Receivables - Other ranged from a high of $6.2 million in FY2018 and a low of $1.1 million during FY2021.
  • Over the past 3 years, Avadel Pharmaceuticals' median Receivables - Other value was $1.4 million (recorded in 2020), while the average stood at $1.4 million.
  • Data for Avadel Pharmaceuticals' Receivables - Other shows a maximum YoY tumbled of 70.78% (in 2019) over the last 5 years.
  • Avadel Pharmaceuticals' Receivables - Other (Yearly) stood at $6.2 million in 2018, then tumbled by 70.78% to $1.8 million in 2019, then declined by 24.88% to $1.4 million in 2020, then decreased by 23.25% to $1.1 million in 2021.